The present invention relates to an inhaler containing an active substance for inhalation and a monitor having one or more sensors for monitoring a patient's adherence and/or compliance. In particular, the invention relates to an inhaler with a monitor with a mounting mechanism that is configurable so that the monitor can be either detachably or permanently attached to the inhaler.
Inhalers, such as dry powder inhalers (DPIs), provide an attractive method for administering medicaments, for example to treat local diseases of the airway or to deliver drugs to the bloodstream via the lungs. The medicament is commonly provided as individual doses, such as a strip having a plurality of blisters. The dose is typically dispensed by the user opening a cap or cover to access a mouthpiece, then operating an actuator, such as a button or lever to release the powder, and finally inhaling through the mouthpiece. In some inhalers (known as “open-inhale-close” inhalers) the cover itself is the actuator, so that there is no separate actuating lever or button. The inhalers usually have a dose counter which displays the number of doses that have been used, or that remain to be used.
The efficacy of treatment is dependent on the patient using the inhaler correctly and as prescribed. Consequently, there is increasing interest in monitoring patient adherence (i.e. whether the patient takes the prescribed number of doses per day, e.g. once or twice daily) and compliance (i.e. whether the patient uses their inhaler correctly, e.g. if they inhale sufficiently strongly to entrain the powder and disperse it into particles that reach the lung).
DPIs typically contain a month's supply of medication. Since adherence/compliance monitors usually contain expensive sensors, electronics etc., they are often provided as separate add-on modules which detachably couple to the inhaler. Thus, when the medication in the inhaler has been used up, the monitor can be detached and then re-attached to a new inhaler. For example, WO 2014/204511 discloses adherence monitors for the Diskus® dry powder inhaler, which may be configured as a casing that fits over the top and bottom portions of the inhaler. The monitor is therefore easy to install and remove. WO 2015/178907 discloses a monitor in the form of an external casing into which the inhaler is inserted. The monitor has friction screws which are tightened in order to secure the monitor to the inhaler. The monitor is therefore removable by loosening the screws.
Alternatively, the monitor may be permanently attached to the inhaler, so that it cannot be inadvertently removed by the user. This ensures that the monitor records adherence/compliance information throughout the lifetime of the inhaler. For example, EP 3552647 discloses a built-in monitor for a Diskus®-type inhaler. The monitor is fixedly mounted to the casing of the inhaler under a cover unit by means of screws. EP 3551263 discloses an integrated monitor for a Diskus®-type inhaler which is located inside the housing of the inhaler. These monitors are not removable.
Thus both removable and permanently attached monitors are required, for different users and/or different products. It would be advantageous to provide a monitor for an inhaler which can be easily configured to be either permanently attached or removable without having to change the design of the monitor.
The present invention addresses this problem and, in a first aspect, provides an inhaler with a monitor having one or more sensors, wherein the monitor is attachable to the inhaler by a mounting mechanism comprising at least one pair of complementary mounting members, wherein one mounting member of the or each pair of mounting members is located on the inhaler and the other mounting member of the or each pair of mounting members is located on the monitor; wherein the mounting mechanism, in particular one or more of the mounting members, is configurable so that the monitor can be detachably mounted on the inhaler in a first configuration of the configurable mounting member(s) and can be permanently attached to (i.e. mounted onto) the inhaler in a second configuration of the configurable mounting member(s).
Each pair of mounting members may comprise a male mounting member and a female mounting member.
The monitor may comprise a male mounting member and the inhaler may comprise a female mounting member, or the inhaler may comprise a male mounting member and the monitor may comprise a female mounting member.
In contrast to the known monitors which are retro-fitted (either detachably or permanently) onto pre-existing inhalers, the inhaler and monitor of the present invention are designed from the start to be used with each other. This allows the mounting mechanism to be configurable so that the monitor can be attached to the inhaler in either a detachable or permanent manner. The single base design provides both the removable and the fixed options, and only a simple additional step is necessary during assembly to select the desired configuration.
In one embodiment, the monitor has two male mounting members and the inhaler has two female mounting members. One or both of the male mounting members may be configurable so that the monitor can be either detachably or permanently attached to (i.e. mounted onto) the inhaler.
The configurable male mounting member may be a clip comprising a primary clip member and a secondary clip member. The corresponding female mounting member may be a slot.
In the first configuration, when the monitor is detachably mounted on the inhaler, the primary clip member engages with the slot and the secondary clip member does not engage with the primary clip member and/or the slot. In the second configuration, when the monitor is permanently mounted on the inhaler, the primary clip member engages with the slot and the secondary clip member engages with the primary clip member and/or the slot.
The secondary clip member may be configurable, e.g. movable from a first position in which it does not engage with the primary clip member and/or the slot to a second position in which it engages with the primary clip member and/or the slot. The secondary clip member may be movable via an orifice in the housing of the inhaler or in the casing of the monitor, for example during assembly of the inhaler. Alternatively, the secondary clip member may be configurable by removing a breakable/detachable part.
The primary clip member may have a body and an enlarged head which acts as a pawl, and the corresponding slot may have a lip and a void, which forms a detent mechanism for holding the head of the primary clip member inside the slot so that the monitor can be mounted on the inhaler and can be detached from the inhaler with a small force (such as less than 30 N).
The secondary clip member may have a head and the primary clip member may have a step. When the monitor is permanently mounted on the inhaler, the head of the secondary clip member may engage with the step the primary clip member as a ratchet and pawl. The head of the secondary clip member may act as the pawl which engages with the step on the primary clip member that acts as the ratchet.
When the monitor is permanently mounted on the inhaler, the secondary clip member may prevent the primary clip member from moving so that the detent mechanism cannot be released. In particular, the head of the secondary clip member may be located inside the slot and may prevent the head of the primary clip member from overcoming the detent mechanism. Thus the monitor can only be detached from the inhaler with a large force (such as greater than 150 N).
The secondary clip member may have a flexible body. The secondary clip member may be a separate component. The secondary clip member may have a removable part.
In a second aspect, the invention provides a monitor for an inhaler, the monitor having one or more sensors, wherein the monitor has at least one configurable mounting member for attaching the monitor to the inhaler so that the monitor can be detachably mounted on the inhaler in a first configuration of the configurable mounting member(s) and can be permanently mounted on the inhaler in a second configuration of the configurable mounting member(s), wherein the at least one configurable mounting member comprises a primary clip member and a secondary clip member.
In a third aspect, the invention provides an inhaler for use with a monitor having one or more sensors, wherein the inhaler has at least one configurable mounting member for attaching the monitor to the inhaler so that the monitor can be detachably mounted on the inhaler in a first configuration of the configurable mounting member(s) and can be permanently mounted on the inhaler in a second configuration of the configurable mounting member(s), wherein the at least one configurable mounting member comprises a primary clip member and a secondary clip member.
The invention will now be further described with reference to the Figures, wherein:
In the context of inhalers, the term “adherence” is normally used to refer to whether the patient takes the prescribed number of doses per day, e.g. once or twice daily. The term “compliance” is normally used to refer to whether the patient uses their inhaler correctly, e.g. if they inhale sufficiently strongly to entrain the powder and disperse it into particles that reach the lung. Consequently, a monitor may be designed to measure adherence and/or compliance, according to the type of sensors that it uses, and how they are configured. In the present application, the term “monitor” therefore refers to a module having one or more sensors that is designed to measure and capture information relating to adherence and/or compliance. However, the monitor does not perform any of the functions associated with dosing the medication, such as a piercing or opening blisters/capsules, de-agglomerating the powder or providing a breath-actuation mechanism. The inhaler therefore operates to dispense the active substance whether the monitor is present or not.
The term “mounting mechanism” refers to a mechanism for mechanically connecting the inhaler and monitor using at least one pair of mounting members with complementary shape such as to engage with each other, wherein one mounting member of each pair is located on the inhaler, and the other is located on the monitor. One of the members (often referred to as “male”) is inserted, clicked or hooked into, and/or caught by, the other member (often referred to as “female”). A male member has a particular shape (such as as a peg or other protrusion) adapted for mechanical engagement with a complementary female member (such as a slot or other cavity). Thus the mounting mechanism locates the monitor in a pre-defined position with respect to the inhaler and provides a retaining force to hold it in position. For example, the mounting mechanism may comprise a clip (male feature) in the form of protrusion with an enlarged head and a corresponding slot (female feature) with a lip. Typically, the male member is somewhat flexible, and, in the detachable configuration, release is easy and achieved e.g. by slightly pressing or pulling the monitor, such as in the case of a snap-fit connection. In the permanent configuration, the movement of the male member is restricted so that it cannot flex, thereby preventing detachment of the monitor.
The term “detachably attached” means that the monitor is intended to be removable by a user, for example using their fingers. This term does not refer to monitors that are intended not to be removable by a user, and which are only removable by applying a very large force, such as with a tool. The terms “removable” and “detachable” are used interchangeably.
The term “permanently attached” means that the monitor is not intended to be removable by a user, for example using their fingers. However, this term does not require that it is completely impossible to remove the monitor (so for example, a permanently attached monitor might be removable by using tools).
The term “configurable” refers to a mounting member, or component thereof, which is designed to have two different positions or states. The state can be selected or changed, in particular during assembly of the inhaler and the monitor. The selection or change can be effected for example by moving (such as bending, flexing, translating) the component; or by removing (such as breaking off) a detachable part of the component.
The inhaler of the invention preferably has a strip of blisters containing powdered medicament, and a mechanism for advancing the blister strip and for opening the blisters which is operated by an actuator. The opening mechanism is suitably a piercer which is mounted on the underside of the mouthpiece. The actuator drives the indexing mechanism to move a blister into alignment with the piercer and then moves the mouthpiece relative to the housing so that the piercer pierces the aligned blister. The actuator may be a lever which causes indexing of the blister strip and piercing of the blisters. Preferably however, the actuator is formed as part of, or is connected to, the cover, so that rotation of the cover causes indexing of the blister strip and piercing of the blisters. The inhaler may be configured to index and pierce one blister on each actuation. Alternatively, it may index and pierce two (or more) blisters on each actuation. For example, it may deliver two (or more) different formulations or medicaments simultaneously.
However, the invention is not limited to this type of inhaler, and for example, could equally be an inhaler which has a passive mouthpiece cover, and a separate actuating lever, as described for example in WO13/175176, or with an inhaler which has a blister disk instead of a blister strip, or a reservoir DPI or a capsule DPI. Moreover, the invention can equally apply to other types of inhaler, such as pressurized metered dose inhalers (pMDI) or soft mist inhalers.
An inhaler and monitor of the invention are shown in
The inhaler shown in
The inhaler 1 shown in
The inner face of the monitor matches the shape of the housing of the inhaler on which it is mounted. The outer face corresponds to the curve defined by the rotation of cover. In other words, it is shaped as an arc of a circle centred on the axis of rotation of the cover, with a radius which is slightly less than the radius of the internal surface of the cover. Thus, when the cover is opened there is a small clearance gap (about 0.5-1 mm) between the internal surface of the cover and outer face of the monitor. This maximises the volume of the monitor within the constraint that it can fit under the cover.
The inner face of the monitor (i.e. the side which abuts the inhaler when the monitor is attached) is shown in
The monitor may be configured so that it is detachable and hence may be transferred to a new inhaler once the medication in the original inhaler has been used up. In this detachable configuration, the monitor can be removed with a force of less than 30 N, which is low enough for elderly or infirm users to be able to detach it. Alternatively, the monitor may be configured so that it is permanently attached to the inhaler. In this fixed configuration, the monitor is capable of resisting attempted removal by a user, and requires a force of e.g. greater than 150 N to remove it. These two configurations are achieved from a single design by designing the second clip 60 so that it can be configured during the factory assembly process in either the permanently mounted state or the detachably mounted state.
In this configuration, the insertion process is reversible: as the head 72 is removed from the slot 14, the lip 17 pushes against the sloping rear face 75, the head 72 is deflected downwards into the void 18, until the ridge 74 rides over the lip 17. The resilience of the body 71 causes the head to deflect back upwards as the front face 73 moves over the lip. Thus sufficient force must be applied to the monitor for the body 71 to be deflected so that the head 72 passes over the lip, i.e. in order to overcome the hold placed on the head by the detent mechanism. Once the second clip has been released from the second slot, the monitor can be moved upwards a short distance so that the first clip can be removed from the first slot. In this manner, the monitor can be detached from the inhaler with a relatively small force (such as less than 30 N), e.g. once all of the doses have been inhaled.
In an alternative arrangement, the step 76 could be provided on the lower surface of the slot 14, and the head 82 of the secondary clip member 80 could protrude downwardly so that when the secondary clip member 80 is inserted into the slot 14, the head 82 would again be held behind the step 76.
In summary, when the secondary clip member is not inserted into the slot (
The user should not be able to inadvertently or misguidedly change from the detachable configuration to the fixed configuration whilst using the monitor. Thus the secondary clip member should be sufficiently flexible that it can be pushed into the fixed configuration during assembly, but sufficiently stiff that a user is not able to push it into the fixed configuration by for example, poking a pin into the aperture. Suitably, the force required to push the secondary clip member into the fixed configuration is greater than 300 N.
The monitor can be attached to the inhaler by inserting the first clip into the first slot, and then the second clip into the second slot as described above. Alternatively, the second clip can first be inserted into the second slot, and then subsequently the first clip can be inserted into the first slot. If the monitor is to be permanently attached to the inhaler, the second clip is placed into the fixed configuration by pushing the secondary clip member into position in the second slot via the orifice.
The secondary clip member could interact with the primary clip member outside the slot rather than inside it, as shown in
In an alternative embodiment, the secondary clip member is a separate component rather than an integral part of the second clip. Thus, when assembling the monitor for the detachable configuration, the secondary clip member is not present at all. On the other hand, when assembling the monitor for the fixed configuration, the secondary clip member is inserted into the slot. The secondary clip member may be included in the clip assembly before mounting the monitor onto the inhaler and then inserted into the slot, for example by pushing a rod through the aperture to move the secondary clip member into position in the slot. Alternatively, the secondary clip member could itself be inserted through the aperture and into the slot. Since the secondary clip member is not present at all in the detachable configuration, there is no possibility of the user inadvertently changing from the detachable configuration to the fixed configuration whilst using the monitor, even if the user poked a pin into the aperture.
Instead of the secondary clip member being movable, it could be rigid (so that it is not movable), but have a part which can be broken off or otherwise removed before or during assembly in order to change from the permanently attached configuration to the removable configuration. For example, in the embodiment shown in
In yet another embodiment, shown in
In the embodiment shown in
In the embodiment shown in
It is only necessary for one of the mounting members to be configurable; nonetheless several or all of the mounting members may be configurable. For example, in the embodiment described above, only the second (lower) clip is configurable. However, the first (upper) clip could alternatively or additionally be configurable. Having more than one configurable mounting member has the advantage that an even greater force would be required to remove the monitor in the fixed configuration; however, increasing the number of configurable mounting members may increase the cost and the complexity of assembly.
In the embodiment shown in
In the embodiment shown in
The invention provides a monitor which can be either detachably or permanently attached to an inhaler using a simple assembly process. Creating the permanent configuration needs only a simple additional step (e.g. pushing a component with a rod) and does not require, for example, a welding or gluing step.
The monitor may have a controller and memory (e.g. a suitable microprocessor) which are configured to process and/or store information read from the sensors relating to patient's usage of the inhaler. The monitor may also include communication means to transmit adherence/compliance information (e.g. via bluetooth) to an external device, such as a computer or smartphone. The information may then be displayed to the patient and/or a medical professional, by means of suitable software, for example a smartphone app. The information may additionally or alternatively be stored on the monitor for subsequent interrogation, or wirelessly transmitted to, for example, an online health platform.
The medicament is suitable for administration by inhalation, for example for the treatment of a respiratory disease. It may include one of more of the following classes of pharmaceutically active material: anticholinergics, adenosine A2A receptor agonists, 2-agonists, calcium blockers, IL-13 inhibitors, phosphodiesterase-4-inhibitors, kinase inhibitors, steroids, CXCR2, proteins, peptides, immunoglobulins such as Anti-IG-E, nucleic acids in particular DNA and RNA, monoclonal antibodies, small molecule inhibitors and leukotriene B4 antagonists. The medicament may include excipients, such as fine excipients and/or carrier particles (for example lactose), and/or additives (such as magnesium stearate, phospholipid or leucine).
Suitable B2-agonists include albuterol (salbutamol), e.g. albuterol sulfate; carmoterol, e.g. carmoterol hydrochloride; fenoterol; formoterol; milveterol, e.g. milveterol hydrochloride; metaproterenol, e.g. metaproterenol sulfate; olodaterol; procaterol; salmeterol, e.g. salmeterol xinafoate; terbutaline, e.g. terbutaline sulphate; vilanterol, e.g. vilanterol trifenatate or indacaterol, e.g. indacaterol maleate. Suitable steroids include budesonide; beclamethasone, e.g. beclomethasone dipropionate; ciclesonide; fluticasone, e.g. fluticasone furoate; mometasone, e.g. mometasone furoate. Suitable anticholinergics include: aclidinium, e.g. aclidinium bromide; glycopyrronium, e.g. glycopyrronium bromide; ipratropium, e.g. ipratropium bromide; oxitropium, e.g. oxitropium bromide; tiotropium, e.g. tiotropium bromide; umeclidinium, e.g. umeclidinium bromide; Darotropium bromide; or tarafenacin.
The active material may include double or triple combinations such as salmeterol xinafoate and fluticasone propionate; budesonide and formoterol fumarate dehydrate; glycopyrrolate and indacaterol maleate; glycopyrrolate, indacaterol maleate and mometasone furoate; fluticasone furoate and vilanterol; vilanterol and umeclidinium bromide; fluticasone furoate, vilanterol and umeclidinium bromide.
Number | Date | Country | Kind |
---|---|---|---|
21174149.1 | May 2021 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2022/063134 | 5/16/2022 | WO |